Skip to main content
SpringerLink
Log in
Book cover

Comparative Issues in the Governance of Research Biobanks pp 301–309Cite as

Scientific and Managerial Premises and Unresolved Issues in Tumour Biobanking Activities

  • Chapter
  • First Online:

  • 922 Accesses

Abstract

Research biobanks are organisations that collect and preserve human biological materials, according to ethical and legal rules, in order to supply researchers with high quality human specimens for scientific purposes, accompanied by as much data as possible. Disease-oriented biobanks are aimed at collecting biomaterials pertaining to specific pathological conditions, and among them are tumour biobanks. High-quality biobanking relies on several aspects, which include long-term funding, appropriate ethical and legal framework, active involvement of patients and the medical community, quality of samples and of the corresponding data, proper regulation of the procedures for distributing biomaterials, appropriate Information Technology (IT) infrastructure, networking in a national and international environment. In this essay we will focus our attention on some of these aspects, describing, in particular, the workflow and organisation of a specific type of biobank: the tumour biobank. Our analysis is based on the experience developed in the recently established Trentino Biobank (TBB), which is a paradigmatic biobanking project in Italy.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    Roden et al. (2008), p. 362.

  2. 2.

    Riegman et al. (2008), p. 213; Oosterhuis et al. (2003), p. 73.

  3. 3.

    Von Walcke‐Wulffen (2009); EuroCryo Saar, November 2009.

  4. 4.

    Macilotti et al. (2008), p. 86.

  5. 5.

    Trentino Biobank, is founded by the Provincial Health Authorities of Trento and by the Fondazione Cassa di Risparmio di Trento e Rovereto, and is a functional structure of the Surgical Pathology Unit of the S. Chiara Hospital of Trento; www.tissuebank.it.

  6. 6.

    Barbareschi et al. (2008), p. 139.

  7. 7.

    Galvagni et al. (2008); p. 116.

  8. 8.

    IARC Working Group Reports (2008); Morente et al. (2006), p. 2684; ISBER (2008), Mager et al. (2007), p. 828.

  9. 9.

    Petrini (2010a), p. 217; Petrini (2010b), p. 1040; Hansson (2010); 340: c2335; Hansson et al. (2006), p. 266.

  10. 10.

    Carter and Betsou (2011), p. 157; Yuille et al. (2010), p. 65.

  11. 11.

    Muyal et al. (2009), p. 9; Strand et al. (2007), p. 38; Mathot et al. (2011), p. 547.

  12. 12.

    Riegman and van Veen (2011), p. 357.

  13. 13.

    Stanta et al. (2011), p. 149.

References

  • Barbareschi M, Cotrupi S, Guarrera GM (2008) Biobanks: instrumentation, personnel and cost analysis. Pathologica 100:139–148

    Google Scholar 

  • Carter A, Betsou F (2011) Quality assurance in cancer biobanking. Biopreserv Biobank 9(2):157–163

    Article  Google Scholar 

  • Galvagni M, Cotrupi S, Barbareschi M (2008) Biobanks and information technology. Pathologica 100:116–138

    Google Scholar 

  • Hansson MG (2010) Need for a wider view of autonomy in epidemiological research. Br Med J 340:c233

    Article  Google Scholar 

  • Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G (2006) Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 7:266–269

    Article  Google Scholar 

  • IARC Working Group Reports (2008) Common minimum technical standards and protocols for biological resource centres dedicated to cancer research. In: Caboux E, Plymoth A, Hainaut P (eds) WorkGroup Report 2. IARC, Lyon

    Google Scholar 

  • ISBER (2008) Best practices for repositories, collection, storage, retrieval and distribution of biological materials for research. Cell Preserv Technol 6(1)

    Google Scholar 

  • Macilotti M, Izzo U, Pascuzzi G, Barbareschi M (2008) Legal aspects of biobanks. Pathologica 100:86–115

    Google Scholar 

  • Mager SR, Oomen MH, Morente MM, Ratcliffe C, Knox K, Kerr DJ, Pezzella F, Riegman PH (2007) Standard operating procedure for the collection of fresh frozen tissue samples. Eur J Cancer 43:828–834

    Article  Google Scholar 

  • Mathot L, Lindman M, Sjoblom T (2011) Efficient and scalable serial extraction of DNA and RNA from frozen tissue samples. Chem Commun 47:547–549

    Article  Google Scholar 

  • Morente MM, Mager R, Alonso S, Pezzella F, Spatz A, Knox K et al (2006) TuBaFrost 2: standardising tissue collection and quality control procedures for a european virtual frozen tissue bank network. Eur J Cancer 42:2684–2691

    Article  Google Scholar 

  • Muyal JP, Muyal V, Kaistha BP, Seifart C, Fehrenbach H (2009) Systematic comparison of RNA extraction techniques from frozen and fresh tissues: checkpoint towards gene expression studies. Diagn Pathol 4:9

    Article  Google Scholar 

  • Oosterhuis JW, Coebergh JW, van Veen EB (2003) Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer 3:73–77

    Article  Google Scholar 

  • Petrini C (2010a) “Broad” consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose. Soc Sci Med 70:217–220

    Article  Google Scholar 

  • Petrini C (2010b) Ethical issues with informed consent from potential living kidney donors. Transplant Proc 42:1040–1042

    Article  Google Scholar 

  • Riegman PHJ, van Veen E (2011) Biobanking residual tissues. Hum Genet 130:357–368

    Article  Google Scholar 

  • Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P (2008) Biobanking for better healthcare. Mol Oncol 2:213–222

    Article  Google Scholar 

  • Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, Masys DR (2008) Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 84(3):362–369

    Article  Google Scholar 

  • Stanta G, Bonin S, Machado I, Llombart-Bosch A (2011) Models of biobanking and tissue preservation: RNA quality in archival samples in pathology laboratories and “In Vivo Biobanking” by tumor xenografts in nude mice-two models of quality assurance in pathology. Biopreserv Biobank 9(2):149–155

    Article  Google Scholar 

  • Strand C, Enell J, Hedenfalk I, Fernö M (2007) RNA quality in frozen breast cancer samples and the influence on gene expression analysis a comparison of three evaluation methods using microcapillary electrophoresis traces. BMC Mol Biol 8:38

    Article  Google Scholar 

  • Von Walcke-Wulffen V (2009) Case study on the economic impact of biobanks. http://www.bbmri.eu/index.php/publications-a-reports. Illustrated by EuroCryo Saar – Fraunhofer Institut for Biomedical Engineering – Nov 2009

  • Yuille M, Illig T, Hveem K, Schmitz G, Hansen J, Neumaier M, Tybring G, Wichmann E, Ollier B (2010) Laboratory management of samples in biobanks: European Consensus Expert Group report. Biopreserv Biobank 8(1):65–69

    Article  Google Scholar 

Download references

Acknowledgements

Trentino Biobank is supported by Fondazione Cassa di Risparmio di Trento e Rovereto and by the Autonomous Province of Trento through the Provincial Health Service Authority.

Author information

Authors and Affiliations

  1. Unit of Surgical Pathology, Laboratory of Molecular Pathology, S. Chiara Hospital, Trento, Italy

    Mattia Barbareschi

  2. Trentino Biobank, S. Chiara Hospital, Trento, Italy

    Mattia Barbareschi, Silvia Fasanella, Chiara Cantaloni & Silvia Giuliani

Authors
  1. Mattia Barbareschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Fasanella
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiara Cantaloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Giuliani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mattia Barbareschi .

Editor information

Editors and Affiliations

  1. University of Trento, via Verdi 73, Trento, 38122, Italy

    Giovanni Pascuzzi

  2. , Faculty of Law, University of Trento, Via Verdi 53, Trento, 38122, Italy

    Umberto Izzo

  3. University of Trento, Via Verdi 53, Trento, 38122, Italy

    Matteo Macilotti

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Barbareschi, M., Fasanella, S., Cantaloni, C., Giuliani, S. (2013). Scientific and Managerial Premises and Unresolved Issues in Tumour Biobanking Activities. In: Pascuzzi, G., Izzo, U., Macilotti, M. (eds) Comparative Issues in the Governance of Research Biobanks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-33116-9_17

Download citation

Publish with us

Policies and ethics

Search

Navigation